News
4317 posts · page 27 of 180
Trump Administration Pushes A.I. in Healthcare Amid Safety Concerns
The U.S. government advances A.I. in medical care, sparking safety and ethical debates.
Pennsylvania Records Fourth Measles Death, First in 35 Years
Pennsylvania confirms a fourth measles-related death, marking the first fatalities from the virus in decades.
Lawsuit Alleges Trump Administration Blocked NIH Grants to Suppress Science
A new lawsuit claims the Trump administration obstructed NIH grants, accusing it of scientific censorship.
IU Biologist Mengting Han Secures $2.38M NIH Avenir Award
Mengting Han of IU Bloomington receives $2.38M from NIH for pioneering addiction research.
NIH Unveils $21 Million Effort on Sex-Specific Hormonal Research
The NIH commits $21 million to explore sex-specific hormonal biology, aiming to enhance health outcomes through targeted research.
GE HealthCare Eyes $1 Billion Acquisition of Sofie Biosciences
GE HealthCare is reportedly in advanced talks to acquire radiopharmaceutical firm Sofie Biosciences for $1 billion, aiming to enhance its diagnostics division.
AIIMS Workshop Targets Enhanced Education on Cardiometabolic Diseases
AIIMS New Delhi hosts a workshop to strengthen cardiometabolic disease education, engaging experts and policymakers.
Molbio Diagnostics Reports Rs 52.7 Crore Profit in Q1 Following IPO
Molbio Diagnostics sees a turnaround with Rs 52.7 crore profit in Q1, driven by robust Truenat test-kit sales.
Indian AI Cancer Care Platform iOncology.ai Spotlighted in BRICS Journal
iOncology.ai, an AI platform developed by AIIMS and C-DAC, is featured in the BRICS Health Journal for its potential to transform cancer care in emerging economies.
Waystar Considers Sale Amid Market Challenges, Sources Reveal
Waystar explores strategic options, including a sale, as its market value declines amid software sector challenges.
Gillibrand Pushes Congressional Focus on Menopause Amid Midterms
Sen. Gillibrand urges Congress to address menopause, a neglected health issue affecting millions.
U.S. Pushes AI in Healthcare Amid Safety, Investor Concerns
Federal AI projects in healthcare spark debate over safety and investor influence.
Pennsylvania Records Fourth Measles Death After 35-Year Hiatus
Pennsylvania's fourth measles-related death underscores the risk of declining vaccination rates.
GE HealthCare Eyes $1 Billion Acquisition of Sofie Biosciences
GE HealthCare may soon acquire Sofie Biosciences for $1 billion, enhancing its diagnostics arm.
AIIMS Hosts Workshop to Enhance Cardiometabolic Disease Education
AIIMS New Delhi convenes experts to improve cardiometabolic disease education under the PEP program.
Molbio Diagnostics Reports Rs 52.7 Crore Profit in Q1 After IPO
Molbio Diagnostics posts Rs 52.7 crore profit in Q1, reversing last year's loss after successful IPO.
iOncology.ai: Indian AI Platform for Cancer Care Gains BRICS Spotlight
iOncology.ai, developed by AIIMS and C-DAC, is highlighted in a BRICS health journal for its potential to transform cancer care in emerging economies.
Waystar Mulls Strategic Options, Including Potential Sale
Waystar is exploring strategic options that may include a sale, amid a 24% decline in market value.
Gillibrand Calls on Congress to Address Menopause Awareness
Senator Gillibrand urges Congress to tackle menopause, a neglected health issue affecting millions, amid midterm election chaos.
Trump Administration Pushes A.I. in Healthcare Amid Safety Concerns
Federal A.I. initiatives in healthcare spark debate over safety and investor influence.
Pennsylvania Sees Fourth Measles Death in 2026, First in 35 Years
Pennsylvania confirms a fourth measles-related death in 2026, marking the first fatalities from the virus in the state in 35 years.
GE HealthCare Eyes $1 Billion Acquisition of Sofie Biosciences
GE HealthCare is in advanced discussions to acquire Sofie Biosciences for $1 billion, enhancing its cancer diagnostics capabilities.
AIIMS Workshop Aims to Enhance Cardiometabolic Disease Education
AIIMS New Delhi convenes experts to improve training for cardiometabolic disease management.
Molbio Diagnostics Reports Rs 52.7 Crore Profit in Q1 After IPO
Molbio Diagnostics swings to a Rs 52.7 crore profit in Q1, buoyed by Truenat test-kit sales, following its recent IPO.